News

Stay up to date on our latest stories.

Filters

Hikma Board appoints Cynthia Schwalm as Director

Press Release, Corporate
Hikma Board appoints Cynthia Schwalm as Director

Hikma establishes partnership with Melinta in MENA

Press Release, Product
Hikma establishes partnership with Melinta in MENA

Notice of results

Press Release, Corporate
Notice of results

Hikma launches Abiraterone Acetate Tablets

Press Release, Product
Hikma launches Abiraterone Acetate Tablets

Hikma launches Mitomycin for Injection, USP

Press Release, Product
Hikma launches Mitomycin for Injection, USP

Hikma Participates in 2019 World Economic Forum Annual Meeting in Davos, Switzerland

Press Release, Responsibility
Hikma Participates in 2019 World Economic Forum Annual Meeting in Davos, Switzerland

Hikma to present at 37th Annual J.P. Morgan Healthcare Conference

Press Release, Corporate
Hikma to present at 37th Annual J.P. Morgan Healthcare Conference

Hikma announces exclusive agreement with Sciecure Pharma for niche injectable anti-viral medicine

Press Release, Product
Hikma announces exclusive agreement with Sciecure Pharma for niche injectable anti-viral medicine

Hikma launches Dalfampridine Extended-release Tablets

Press Release, Product
Hikma launches Dalfampridine Extended-release Tablets

Hikma launches Clobazam Oral Suspension and Clobazam Tablets

Press Release, Product
Hikma launches Clobazam Oral Suspension and Clobazam Tablets

Hikma demonstrates support for US pharmacists and patient safety

Press Release, Corporate
Hikma demonstrates support for US pharmacists and patient safety

Hikma announces exclusive licensing and supply agreement with Hansoh Pharma for suite of injectable oncology medicines

Press Release, Product
Hikma announces exclusive licensing and supply agreement with Hansoh Pharma for suite of injectable oncology medicines

Hikma launches Triazolam Tablets

Press Release, Product
Hikma launches Triazolam Tablets

Hikma announces global agreement with Vectura to develop generic versions of GSK’s Ellipta® portfolio

Press Release, Corporate
Hikma announces global agreement with Vectura to develop generic versions of GSK’s Ellipta® portfolio

Hikma updates on current trading and raises 2018 guidance

Press Release, Corporate
Hikma updates on current trading and raises 2018 guidance